Custom TaqMan™ Small RNA Assay
Product Image
Applied Biosystems™

Custom TaqMan™ Small RNA Assay

Green features
Custom TaqMan Small RNA Assays use TaqMan Real-Time PCR Assays for the analysis of any small RNA molecule. The novelRead more
Have Questions?
Change viewbuttonViewtableView
Catalog NumberQuantity
4440418XS (25 RT/75 PCR reactions), made to order
4398987S (50 RT/150 PCR reactions), made to order
4398988M (750 RT/750 PCR reactions), made to order
4398989L (2900 RT/2900 PCR reactions), made to order
Catalog number 4440418
Price (CNY)
4,495.00
Each
Order now
Quantity:
XS (25 RT/75 PCR reactions), made to order

Custom TaqMan Small RNA Assays use TaqMan Real-Time PCR Assays for the analysis of any small RNA molecule. The novel adaptations in TaqMan Assay design developed for the study of miRNAs are ideal for analysis of any small nucleic acid less than 200 bases long, including newly discovered miRNAs, Piwi-interacting RNA (piRNA), small nuclear RNA (snRNA), and small nucleolar RNA (snoRNA).

Flexible and convenient ordering—easy process with our secure Custom TaqMan Small RNA Assay design tool
Versatile application—use for the analysis of any small RNA from any species
Reliable outcome—pre-formulated assays are optimized to run under universal conditions
Powerful miRNA quantitation—the same sensitivity, specificity, and reproducibility as predesigned TaqMan MicroRNA Assays

Sophisticated design pipeline
The miRPipe Small RNA Assay design pipeline is founded on our extensive background and bioinformatics expertise designing TaqMan Gene Expression Assays. To detect very small targets, it includes design features based on empirical data gathered over years of experiments. The resulting automated pipeline includes built-in flexibility features enabling design of assays for the broadest assortment of small RNA sequences. The benefits of TaqMan Assay technology are ideal for analysis of virtually any small RNA, enabling results you can trust from the very first experiment.

Pre-formulated assay
• Forward primer: 900 nM
• Reverse primer: 900 nM
• FAM-MGB probe: 250 nM
• RT sequences: 50 nM

Ordering information
First, bioinformatically qualify your sequence target for specificity and sequence quality, then use the Custom TaqMan Small RNA Assay Design Tool to input your sequence and submit it for assay design. This easy-to-use tool is a secure and confidential. If we are unable to design or manufacture an assay for your sequence target of interest, you will not be charged.
 

For Research Use Only. Not for use in diagnostic procedures.
Specifications
No. of Reactions25 reactions (PCR), 75 reactions (RT-PCR)
Product LineTaqMan™
QuantityXS (25 RT/75 PCR reactions), made to order
Shipping ConditionRoom Temperature
Concentration20X (Assay), 5X (RT Primer)
For Use With (Application)Gene Expression
FormLiquid
Unit SizeEach
Contents & Storage
• 1 tube containing RT primer at concentration of 5X (XS and S sizes), 20X (M size), or 60X (L size)
• 1 tube containing a 20X (XS, S, and M sizes) or 60X (L size) mix of pre-formulated assay (1 probe and 2 primers).

Store at -15 to -25°C.

Frequently asked questions (FAQs)

What are the performance specifications of the TaqMan miRNA assays?

The TaqMan miRNA asays are guaranteed to meet the following:
Dynamic Range: > 6 logs10 with > 0.97 linearity (R2 value)
Specificity: Majority of assays have < 5% cross reactivity with closely related sequences. NTC background: Ct > 38.0
Lot-to-Lot Reproducibility: Difference between Ct's < 0.6 Ct when different lots of an assay are run with the same sample and master mix from the same lot on the sample plate
Amplification Efficiency: ranging from 90-110% across 5 logs10

Please see the document “TaqMan Assays QPCR Guarantee Program” for more details.

What data analysis tools do you recommend?

If you are using an Applied Biosystems instrument, we recommend using Expression Suite to analyze data from the TaqMan MicroRNA Array Cards. After importing the .sds or .eds files, you can perform all the QC and data analysis within the tool. For more details on how to use Expression Suite software, please see this video series: https://learn.thermofisher.com/courses/view/id/325

Do you have data to back up your claim that your TaqMan MicroRNA Assays can accurately distinguish miRNA targets that differ by a single base? Have you tested each TaqMan MicroRNA Assay that is designed to one of two or more closely-related target sequences?

It is well understood within the miRNA community that designing assays for miRNAs is challenging due to their short length (<22 bases) and closely related sequences. Although we have not tested cross reactivity of every closely related species, we have demonstrated that we can achieve <5% cross reactivity between a single nucleotide mismatch. Specificity of an assay depends on the number of mismatches to its closest homologue, the location of the mismatch, and the surrounding bases, making cross reactivity difficult to predict. As a general rule, the most difficult miRNA targets to discriminate are those with minimal mismatches localized to the 5' region of the sequence, and it is close to impossible to design an assay that discriminates between a single mismatch at the 5' most base. In addition, the assays in our catalog have been designed to provide a balance between specificity and sensitivity: an assay may be very specific but lack the needed sensitivity, or vice versa. To achieve this balance, and to ensure the highest sensitivity and to reduce false positives, TaqMan MicroRNA Assays must have an NTC background Ct > 38.0 and display good linearity across at least 3 logs10 (ideal R2 > 0.98).

What about isomiRs? Will Thermo Fisher Scientific assays give me good quantification if they only detect one isomer and not all of them?

Deep sequencing analysis of mature miRNAs revealed that many miRNAs have either an addition or deletion of 1-3 bases at the 3' and less frequently at the 5' terminal end. These are often referred to as isomiRs. The sequence deposited in miRBase is the canonical sequence derived by aligning sequences from current deep sequencing data. Thus far, there has been no biological relevance attached to these different forms since they exclusively occur outside the seed sequence. For that reason, the changes detected in the expression level of one isomer are proportional to changes within the entire pool. As a result, there may be a shift in raw Ct value using assays targeting two separate isomiRs. However, the relative expression ddCt has been demonstrated to be roughly the same. It should be noted that, although TaqMan MicroRNA Assays are designed to be sequence specific, they will detect a small spectrum of isomiRs. Depending on the number and composition at the 3' end, an assay may detect the +1 and +2 isomiRs but not the -1 or -2 forms.

What I can do to minimize variability when using assays?

Use multiple replicates and consider, when possible, using an overall study control that is used in every assay to monitor potential day-to-day/run-to-run/across study variability.